European Commission takes on Big Pharma

The Lancet

Volumn 374, Issue 9690, 2009, Pages 599-600

  den Exter, André ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; ECONOMIC ASPECT; EUROPE; EUROPEAN UNION; PRIORITY JOURNAL;

EID: 68849115978     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61370-2     Document Type: Note

References (3)

1. European Commission. Pharmaceutical sector inquiry (July 8, 2009). http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry (accessed July 8, 2009).
2. European Commission. DG Competition. Pharmaceutical sector inquiry: preliminary report (Nov 28, 2008). http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry (accessed Jan 1, 2009).
3. UN General Secretary. Promotion and protection of human rights: human rights questions, including alternative approaches for improving the effective enjoyment of human rights and fundamental freedoms. The right to health (Aug 11, 2008). http://daccessdds.un.org/doc/UNDOC/GEN/N08/456/47/PDF/N0845647.pdf?OpenElement (accessed July 9, 2009).